Global license agreement to build up, commercialize cancer treatment is executed by Oxis Biotech – Tribune Reporter

Posted by Social Media | Sep 8, 2015 | Coral Gables | 0 |

Global license agreement to build up, commercialize cancer treatment is executed by Oxis Biotech – Tribune Reporter

Oxis Biotech, Inc. (OXIS), owned part of Oxis International, Inc. (OTC: OXIS) and (Euronext Paris: OXI.PA) released today the performance of a special worldwide license contract to further create and commercialize DT2219ARL, a story remedy for the remedy of various human B – Cell cancers, leukemias and lymphomas.

Source: www.tribunereporter.com

About The Author

Social Media

SPONSORS

Recent Posts

Why You Should Have Legal Representation February 11, 2020
Important Reasons to Have Life Insurance December 10, 2019
Millennials More Likely to Fall for Fraud, According to the FTC November 2, 2019
Porsche 996 November 1, 2019
Fibroblast – What is it? October 14, 2019
Mortgage Fraud: Everything You Need To Know and Why You Should Not Commit A Crime October 5, 2019
What is Cosmetic Dentistry? October 1, 2019
Porsche 964 August 1, 2019
Metronomic – Plaza Celia Ribbon Cutting October 20, 2017
Despite Rising Seas and Bigger Storms, Florida’s Land Rush Endures – The New York Times September 18, 2017